Dr. Jennifer Flemming is an Associate Professor of Medicine and Public Health Sciences at Queen’s University with clinical training in gastroenterology, hepatology and liver transplantation. After completing her Internal Medicine and Gastroenterology training at Queen’s University, she completed two years of advanced hepatology and a Master’s in Clinical Research at the University of California San Francisco. In her clinical practice she manages a wide variety of patients with chronic liver disease from early disease stages to decompensated cirrhosis, hepatocellular carcinoma and liver transplant. She is a clinician scientist who leads a research program which leverages Ontario administrative data housed at ICES to evaluate the epidemiology and outcomes of patients with chronic liver diseases and cirrhosis and is the ICES-Queen’s Site Director. Her research has been supported by the Canadian Institutes for Health Research (CIHR), American Association for the Study of Liver Disease (AASLD), the American Gastroenterological Association (AGA) and the Canadian Donation and Transplantation Research Program. In addition, Dr. Flemming is an Associate Editor of the American Journal of Gastroenterology, serves as the Chair for the Guidelines Committee of the Canadian Association for the Study of Liver Disease (CASL), and is a member of the CASL Equity, Diversity and Inclusion committee, AASLD Women’s Initiatives Committee, and the Canadian Task Force on Preventive Health Care.
Jennifer Flemming, Associate Professor, Queen's University